BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35540106)

  • 1. Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure.
    Graupera I; Isus L; Coll M; Pose E; Díaz A; Vallverdú J; Rubio-Tomás T; Martínez-Sánchez C; Huelin P; Llopis M; Solé C; Fondevila C; Lozano JJ; Sancho-Bru P; Ginès P; Aloy P
    JHEP Rep; 2022 Jun; 4(6):100482. PubMed ID: 35540106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.
    Blaya D; Pose E; Coll M; Lozano JJ; Graupera I; Schierwagen R; Jansen C; Castro P; Fernandez S; Sidorova J; Vasa-Nicotera M; Solà E; Caballería J; Trebicka J; Ginès P; Sancho-Bru P
    JHEP Rep; 2021 Apr; 3(2):100233. PubMed ID: 33665588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
    Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
    J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study.
    Lin S; Zhang K; Zhang J; Wang M; Velani B; Zhu Y
    Liver Int; 2019 May; 39(5):854-860. PubMed ID: 30753752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
    Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
    J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure.
    Satsangi S; Duseja A; Sachdeva M; Tomer S; Arora SK; Taneja S; Dhiman RK; Chawla YK
    PLoS One; 2018; 13(7):e0200644. PubMed ID: 30020985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis.
    Clària J; Curto A; Moreau R; Colsch B; López-Vicario C; Lozano JJ; Aguilar F; Castelli FA; Fenaille F; Junot C; Zhang I; Vinaixa M; Yanes O; Caraceni P; Trebicka J; Fernández J; Angeli P; Jalan R; Arroyo V
    J Hepatol; 2021 Nov; 75(5):1116-1127. PubMed ID: 34245803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.
    Wirtz TH; Reuken PA; Jansen C; Fischer P; Bergmann I; Backhaus C; Emontzpohl C; Reißing J; Brandt EF; Koenen MT; Schneider KM; Schierwagen R; Brol MJ; Chang J; Zimmermann HW; Köse-Vogel N; Eggermann T; Kurth I; Stoppe C; Bucala R; Bernhagen J; Praktiknjo M; Stallmach A; Trautwein C; Trebicka J; Bruns T; Berres ML
    JHEP Rep; 2021 Apr; 3(2):100221. PubMed ID: 33659891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
    Kerbert AJC; Gupta S; Alabsawy E; Dobler I; Lønsmann I; Hall A; Nielsen SH; Nielsen MJ; Gronbaek H; Amoros À; Yeung D; Macnaughtan J; Mookerjee RP; Macdonald S; Andreola F; Moreau R; Arroyo V; Angeli P; Leeming DJ; Treem W; Karsdal MA; Jalan R
    JHEP Rep; 2021 Dec; 3(6):100355. PubMed ID: 34805815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.
    Ariza X; Graupera I; Coll M; Solà E; Barreto R; García E; Moreira R; Elia C; Morales-Ruiz M; Llopis M; Huelin P; Solé C; Fabrellas N; Weiss E; Nevens F; Gerbes A; Trebicka J; Saliba F; Fondevila C; Hernández-Gea V; Fernández J; Bernardi M; Arroyo V; Jiménez W; Deulofeu C; Pavesi M; Angeli P; Jalan R; Moreau R; Sancho-Bru P; Ginès P;
    J Hepatol; 2016 Jul; 65(1):57-65. PubMed ID: 26988732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis.
    Xu M; Kong M; Yu P; Cao Y; Liu F; Zhu B; Zhang Y; Lu W; Zou H; You S; Xin S; Duan Z; Han T; Chen Y
    Front Med (Lausanne); 2021; 8():750061. PubMed ID: 34722587
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic studies in acute-on-chronic liver failure.
    Kumar A; Das K; Sharma P; Mehta V; Sharma BC; Sarin SK
    Dig Dis Sci; 2009 Apr; 54(4):869-78. PubMed ID: 18688717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
    Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
    JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
    J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation.
    Monteiro S; Grandt J; Uschner FE; Kimer N; Madsen JL; Schierwagen R; Klein S; Welsch C; Schäfer L; Jansen C; Claria J; Alcaraz-Quiles J; Arroyo V; Moreau R; Fernandez J; Bendtsen F; Mehta G; Gluud LL; Møller S; Praktiknjo M; Trebicka J
    Gut; 2021 Feb; 70(2):379-387. PubMed ID: 32241903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
    Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
    Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
    Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
    Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.